Re-emergence of childhood stuttering in parkinson's disease: A hypothesis

Movement Disorders

Volumn 16, Issue 1, 2001, Pages 114-118

  Shahed, Joohi ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Parkinson's disease; Stuttering

Indexed keywords

ADULT; ADULTHOOD; ALZHEIMER DISEASE; ARTICLE; AVOIDANCE BEHAVIOR; CEREBROVASCULAR ACCIDENT; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEAD INJURY; HUMAN; INTERVIEW; LATENT PERIOD; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; SELF EVALUATION; SPEECH ARTICULATION; STUTTERING;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RECURRENCE; SEVERITY OF ILLNESS INDEX; STUTTERING;

EID: 0035241261     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200101)16:1<114::AID-MDS1004>3.0.CO;2-2     Document Type: Article

References (45)

1. Bloodstein O, ed. A handbook on stuttering, 5th Ed. San Diego, CA: Singular Publishing Group, Inc.; 1995. p 105-143.
2. Andrews G, Craig A, Feyer A, Hoddinott S, Howie P, Neilson M. Stuttering: a review of research findings and theories circa 1982. J Speech Hear Disord 1983;48:226-246.
3. Andrews G. The epidemiology of stuttering. In: Curlee RF, Perkins WH, eds. Nature and treatment of stuttering: new directions. San Diego: College-Hill Press, Inc.; 1984. p 1-12.
4. Yairi E, Ambrose NG, Paden EP, Throneburg RN. Predictive factors of persistence and recovery: Pathways of childhood stuttering. J Commun Disord 1996;29:51-77.
5. Yairi E, Ambrose NG. Early childhood stuttering I: Persistency and recovery rates. J Speech Lang Hear Res 1999;42:1097-1112.
6. Mazzucchi A, Moretti G, Carpeggiani P, Parma M, Paini P. Clinical observations on acquired stuttering. Br J Disord Commun 1981;16:19-30.
7. Quinn T, Andrews G. Neurological stuttering-a clinical entity? J Neurol Neurosurg Psychiatry 1977;40:699-701.
8. Rosenbek J, Messert B, Collins M, Wertz RT. Stuttering following brain damage. Brain Lang 1978;6:82-96.
9. Helm NA, Butler RB, Canter GJ. Neurogenic acquired stuttering. J Fluency Disord 1980;5:269-279.
10. Koller WC. Dysfluency (stuttering) in extrapyramidal disease. Arch Neurol 1983;40:175-177.
11. Helm-Estabrooks N, Yeo R, Geschwind N, Freedman M, Weinstein C. Stuttering: disappearance and reappearance with acquired brain lesions. Neurology 1986;36:1109-1112.
12. Lebrun Y, Leleux C, Retif J. Neurogenic stuttering. Acta Neurochir (Wien) 1987;85:103-109.
13. Ludlow CL, Rosenberg J, Salazar A, Grafman J, Smutok M. Site of penetrating brain lesions causing chronic acquired stuttering. Ann Neurol 1987;22:60-66.
14. Jankovic J, Rajput AH, McDermott MP, Perl DP. Evolution of diagnosis in early Parkinson's disease. Arch Neurol 2000;57: 369-372.
15. Fahn S, Elton RL, Members of the UPDRS Development Committee. The unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease, vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p 153-163, 293-304.
16. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994. p 100-105.
17. Darley FL, Spriestersbach DC, eds. Diagnostic methods in speech pathology, 2d Ed. New York: Harper & Row; 1978. p 309-319.
18. Shumak IC. A speech situation rating sheet for stutterers. In: Johnson W, Leutenegger RR, eds. Stuttering in children and adults. Minneapolis: University of Minnesota Press; 1955. p 341-347.
19. Trotter WD, Bergmann MF. Stutterers' and non-stutterers' reactions to speech situations. J Speech Hear Res 1957;22:40-45.
20. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group, Neurology 1990;40:1529-1534.
21. Yairi E, Ambrose N, Cox N. Genetics of stuttering: a critical review. J Speech Hear Res 1996;39:771-784.
22. Ambrose NG, Cox NJ, Yairi E. The genetic basis of persistence and recovery in stuttering. J Speech Lang Hear Res 1997;40:567-580.
23. Anderson JM, Hughes JD, Rothi LJ, Crucian GP, Heilman KM. Developmental stuttering and Parkinson's disease: The effects of levodopa treatment. J Neurol Neurosurg Psychiatry 1999;66:776-778.
24. Mlcoch AG. Diagnosis and treatment of Parkinsonian dysarthria. In W.C. Koller, ed. Handbook of Parkinson's Disease, 2d Ed. New York: Marcel Dekker, Inc.; 1992. p 227-254.
25. Parkinson Study Group. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol 1989;46: 1052-1060.
26. Critchley EMR. Speech disorders of Parkinsonism: a review. J Neurol Neurosurg Psychiatry 1981;44:751-758.
27. Stewart C, Winfield L, Hunt A, Bressman SB, Fahn S, Blitzer A, Brin MF. Speech dysfunction in early Parkinson's disease. Mov Disord 1995;10:562-565.
28. Ho AK, Iansek R, Bradshaw JL. Regulation of Parkinsonian speech volume. The effect of interlocutor distance. J Neurol Neurosurg Psychiatry 1999; 67:199-202.
29. Carluer M, Marie RM, Lambert J, Defer GL, Coskun O, Rossa Y. Acquired and persistent stuttering as the main symptom of striatal infarction. Mov Disord 2000 (in press).
30. Kiziltan G, Akalin MA. Stuttering may be a type of action dystonia. Mov Disord 1996;11:278-282.
31. Scott B, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology 1996;46:68-74.
32. Wu JC, Maguire G, Riley G, et al. Increased dopamine activity associated with stuttering. NeuroReport 1997;8:767-770.
33. Leckman J, Cohen D, Goetz C, Jankovic J. Tourette syndrome-pieces of the puzzle. In: Cohen D, Jankovic J, Goetz C, eds. Tourette syndrome, Advanced Neurology. Philadelphia: Lippincott, Williams, and Wilkins; 2000 (in press).
34. Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987;41:701-741.
35. Abwender DA, Trinidad KS, Jones KR, Como PG, Hymes E, Kurlan R. Features resembling Tourette's syndrome in developmental stutterers. Brain Lang 1998;62:455-462.
36. Brady JP. The pharmacology of stuttering: a critical review. Am J Psychiatry 1991;148:1309-1316.
37. Brady JP. Drug-induced stuttering: a review of the literature. J Clin Psychopharm 1998;18:50-54.
38. Maguire GA, Gottschalk LA, Riley GD, Franklin DL, Bechtel RJ, Ashurst J. Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity. Comp Psych 1999;40:308-314.
39. Supprian T, Retz W, Deckert J. Clozapine-induced stuttering: epileptic brain activity? Am J Psychiatry 1999;156:1663-1664.
40. Riggs JE, Nelson LJ, Lanham JE. Reemergence of stuttering after focal cerebral insult. Arch Neurol 1983;40:260.
41. Grant AC, Biousse V, Cook AA, Newman NJ. Stroke-associated stuttering. Arch Neurol 1999;56:624-627.
42. Benke T, Hohenstein C, Poewe W, Butterworth B. Repetitive speech phenomenon in Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:319-325.
43. Ciabarra AM, Elkind MS, Roberts JK, Marshall RS. Subcortical infarction resulting in acquired stuttering. J Neurol Neurosurg Psychiatry 2000;69:546-549.
44. Fox PT, Ingham RJ, Ingham JC, et al. Brain correlates of stuttering and syllable production. A PET performance-correlation analysis. Brain 2000;123:1985-2004.
45. Ludlow CL. Stuttering: dysfunction in a complex and dynamic system. Brain 2000;123:1983-1984.